SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tove Henriksen, Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians, Neurodegenerative Disease Management, 2014, 4, 3, 271

    CrossRef

  2. You have free access to this content2
    Thomas Müller, Marion Marg, Hartmut Rothe, Matthias Küchler, Continuous Subcutaneous Apomorphine Infusion Improves Severe Restless Legs Syndrome, Movement Disorders Clinical Practice, 2014, 1, 3
  3. 3
    Fabrizio Stocchi, Paola Stirpe, The relevance of dopaminergic level in nocturnal disability in Parkinson’s disease: implications of continuous dopaminergic stimulation at night to treat the symptoms, Journal of Neural Transmission, 2014, 121, S1, 79

    CrossRef

  4. 4
    Karoline Wenzel, Carl Nikolaus Homann, Giovanni Fabbrini, Carlo Colosimo, The role of subcutaneous infusion of apomorphine in Parkinson’s disease, Expert Review of Neurotherapeutics, 2014, 14, 7, 833

    CrossRef

  5. 5
    Antoniya Todorova, Pablo Martinez-Martin, Anne Martin, Alexandra Rizos, Prashanth Reddy, K. Ray Chaudhuri, Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease, Basal Ganglia, 2013, 3, 2, 127

    CrossRef

  6. 6
    Theresa A Zesiewicz, Pablo Martinez-Martin, Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview, Expert Review of Neurotherapeutics, 2013, 13, 12, 1329

    CrossRef

  7. 7
    Andres Ceballos-Baumann, Eskalationstherapie mit Hirnstimulation und Medikamentenpumpen, DNP - Der Neurologe und Psychiater, 2013, 14, 12, 56

    CrossRef

  8. 8
    K. Ray Chaudhuri, Alexandra Rizos, Kapil D. Sethi, Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?, Journal of Neural Transmission, 2013, 120, 9, 1305

    CrossRef

  9. 9
    Marcelo M.S. Lima, Sleep disturbances in Parkinson's disease: The contribution of dopamine in REM sleep regulation, Sleep Medicine Reviews, 2013, 17, 5, 367

    CrossRef

  10. 10
    Antoniya Todorova, K. Ray Chaudhuri, Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 12, 1073

    CrossRef

  11. 11
    Francisco Grandas, Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease, Expert Review of Neurotherapeutics, 2013, 13, 12, 1343

    CrossRef

  12. You have free access to this content12
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  13. 13
    C. Ossig, H. Reichmann, Treatment of Parkinson’s disease in the advanced stage, Journal of Neural Transmission, 2013, 120, 4, 523

    CrossRef

  14. 14
    Pouya Movahed, M. Tanya Mitra, K. Ray Chaudhuri, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  15. 15
    Pouya Movahed, M Mitra, K Chaudhuri, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  16. 16
    Francesca Del Sorbo, Alberto Albanese, Clinical management of pain and fatigue in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S233

    CrossRef

  17. 17
    Gunnar Wasner, Günther Deuschl, Pains in Parkinson disease—many syndromes under one umbrella, Nature Reviews Neurology, 2012, 8, 5, 284

    CrossRef

  18. 18
    Maartje Louter, Willemijn C. C. A. Aarden, Joy Lion, Bastiaan R. Bloem, Sebastiaan Overeem, Recognition and diagnosis of sleep disorders in Parkinson’s disease, Journal of Neurology, 2012, 259, 10, 2031

    CrossRef

  19. 19
    Kemal Bayulkem, Grisel Lopez, Clinical approach to nonmotor sensory fluctuations in Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 82

    CrossRef

  20. 20
    M Rosario Luquin-Piudo, Pilar Sanz, Dopamine Receptors, Motor Responses, and Dopaminergic Agonists, The Neurologist, 2011, 17, S2

    CrossRef

  21. 21
    Rüdiger Hilker, Angelo Antonini, Per Odin, What is the best treatment for fluctuating Parkinson’s disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?, Journal of Neural Transmission, 2011, 118, 6, 907

    CrossRef

  22. 22
    Nir Giladi, Andreas Fichtner, Werner Poewe, Babak Boroojerdi, Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s disease, Journal of Neural Transmission, 2010, 117, 12, 1395

    CrossRef

  23. 23
    K. Ray Chaudhuri, Kartik Logishetty, Dopamine receptor agonists and sleep disturbances in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S101

    CrossRef

  24. 24
    K Ray Chaudhuri, Anthony HV Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, 2009, 8, 5, 464

    CrossRef

  25. 25
    William G. Ondo, Restless Legs Syndrome, Neurologic Clinics, 2009, 27, 3, 779

    CrossRef

  26. 26
    William G. Ondo, Restless Legs Syndrome, Neurologic Clinics, 2005, 23, 4, 1165

    CrossRef

  27. 27
    R. Giuffrida, F.J.G. Vingerhoets, J. Bogousslavsky, J. Ghika, Syndromes douloureux de la maladie de Parkinson, Revue Neurologique, 2005, 161, 4, 407

    CrossRef

  28. 28
    Jean-Jacques ASKENASY, Trying to understand sleep in Parkinson's disease patients, Sleep and Biological Rhythms, 2005, 3, 1
  29. 29
    Pedro Braga-Neto, Francisco Pereira da Silva-Júnior, Francisca Sueli Monte, Pedro F.C. de Bruin, Veralice M.S. de Bruin, Snoring and excessive daytime sleepiness in Parkinson's disease, Journal of the Neurological Sciences, 2004, 217, 1, 41

    CrossRef

  30. 30
    José Haba-Rubio, Luc Staner, Françoise Cornette, Erik Lainey, Rémy Luthringer, Jean Krieger, Jean P Macher, Acute low single dose of apomorphine reduces periodic limb movements but has no significant effect on sleep arousals: a preliminary report, Neurophysiologie Clinique/Clinical Neurophysiology, 2003, 33, 4, 180

    CrossRef

  31. 31
    Diego Garcia-Borreguero, Oscar Larrosa, Mauricio Bravo, Parkinson's disease and sleep, Sleep Medicine Reviews, 2003, 7, 2, 115

    CrossRef

  32. 32
    Robert G Holloway, Kevin M Biglan, A review of pramipexole and its clinical utility in Parkinson’s disease, Expert Opinion on Pharmacotherapy, 2002, 3, 2, 197

    CrossRef

  33. 33
    Karin Stiasny, Wolfgang Hermann Oertel, Claudia Trenkwalder, Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder, Sleep Medicine Reviews, 2002, 6, 4, 253

    CrossRef

  34. 34
    L.S Appiah-Kubi, S Pal, K.Ray Chaudhuri, Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS, Sleep Medicine, 2002, 3, S51

    CrossRef

  35. 35
    J.-J.M Askenasy, Approaching disturbed sleep in late Parkinson's Disease: first step toward a proposal for a revised UPDRS, Parkinsonism & Related Disorders, 2001, 8, 2, 123

    CrossRef

  36. 36
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,
  37. 37
    Joaquim Ferreira, Tiago Mestre, Russell M Hewett, Miguel M Coelho, Mário Rosa, Olivier Rascol, Cristina Sampaio, Therapeutic interventions for sleep disorders in Parkinson's disease, The Cochrane Library,